✦ LIBER ✦

Impact of compliance on drug development:: An FDA perspective

✍ Scribed by M Cavaillé-Coll

Book ID: 117238037
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 47 KB
Volume: 31
Category: Article
ISSN: 0041-1345
DOI: 10.1016/s0041-1345(99)00124-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pediatric Drug Development in Anesthesio

Pediatric Drug Development in Anesthesiology: An FDA Perspective

✍ Rappaport, Bob A.; Schultheis, Lex W.; Mathis, Lisa L.; Roca, Rigoberto A.; Simo 📂 Article 📅 2006 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 106 KB

The impact of compliance on drug develop

The impact of compliance on drug development

✍ J Urquhart 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Predicting Drug–Drug Interactions: An FD

Predicting Drug–Drug Interactions: An FDA Perspective

✍ Lei Zhang; Yuanchao (Derek) Zhang; Ping Zhao; Shiew-Mei Huang 📂 Article 📅 2009 🏛 American Association of Pharmaceutical Scientists 🌐 English ⚖ 155 KB

Stereoisomeric Drugs: FDA'S Policy State

Stereoisomeric Drugs: FDA'S Policy Statement and the Impact on Drug Development

✍ Tomaszewski, John; Rumore, Martha M. 📂 Article 📅 1994 🏛 Informa plc 🌐 English ⚖ 838 KB

An FDA perspective on antiarrhythmic dru

An FDA perspective on antiarrhythmic drugs in phase II trials

✍ Raymond Lipicky 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 331 KB

The FDA perspective on the development o

The FDA perspective on the development of stereoisomers

✍ Wilson H. De Camp 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 723 KB